Results 61 to 70 of about 19,375 (225)
BMC Pregnancy and ChildbirthBackground Uterine leiomyomas are hormone-dependent benign tumors and often begin to shrink after menopause due to the reduction in ovarian steroids. The influence of pregnancy on uterine leiomyomas size remains unclear.
Lifang Zhu-ge +3 more
doaj +1 more source
Environmental Toxicology, EarlyView.ABSTRACT This study investigates how phthalate exposure contributes to uterine fibroid (UF) development by studying the effects of the Mono‐(2‐ethyl‐5‐hydroxyhexyl) phthalate (MEHHP), a metabolite of Di(2‐ethylhexyl) phthalate, on myometrial stem cells (MMSCs).
Somayeh Vafaei +6 more
wiley +1 more source
Sokoto Journal of Medical Laboratory Science, 2016 Uterine leiomyoma is a benign tumour which is non-cancerous from smooth muscle tissue that develops from smooth muscle layer (myometrium) from the uterus.
Mohammed, I.*, Hussein, A.S., Kaoje, A.U., Tangaza, A.M.
doaj
Ultrasound Findings After Uterine Artery Embolisation: Pictorial Essay and Clinical Validation
Journal of Medical Imaging and Radiation Oncology, EarlyView.ABSTRACT Uterine artery embolisation (UAE) is an evidence‐based treatment for symptomatic fibroids and adenomyosis. Ultrasound is commonly utilised for assessment post UAE given its wide availability and low cost; however, contemporary studies describing the typical ultrasound findings post UAE are limited, with a preference for discussion of Magnetic ...
Matthew Lukies +6 more
wiley +1 more source
Leiomyoma in the Retzius space
, 2017 Parauterine location of leiomyomas is observed to be an extremely rare clinical condition. However, when benign or malignant primary tumours are detected in that area, they are often found in the Retzius space.
Dobrosława Sikora-Szczęśniak
core +1 more source
Epidemiologic peculiarities of combined hyperproliph erative processes of female reproductive system [PDF]
Medičnì Perspektivi, 2013 The study involved 622 women of reproductive age with such hyperproliferative processes of the pelvic organs as uterine leiomyoma, endometrial hyperplasia and endometriosis. We studied main epidemiological factors inherent in these diseases.
Potapov V.O. +4 more
doaj
Progestins and uterine leiomyoma
Gynecological Endocrinology, 1999 Myomas are the most frequent benign gynecological tumors and are responsible for several symptoms and complaints. Their etiology is unknown and their pathology and proliferation is poorly understood. Besides the importance of estrogens for development and growth of the myoma, progesterone seems to play an important role in the modulation of mitotic ...
openaire +2 more sources
Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions
Clinical Endocrinology, EarlyView.ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley +1 more source
Risk Factors of Uterine Leiomyoma in Women of Reproductive Ages
Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2009 BACKGROUND AND OBJECTIVE: Uterine leiomyoma is the most common benign pelvic tumors with an unknown etiology. There are contradictory results about risk factors of uterine leiomyoma which affiliated to genetic or hormonal theories, in different studies ...
SH Sharami,, Z Zahiri,, M Ghanaie
doaj
Current Oncology, 2022 Background/Aim: Patients with uterine sarcoma comprise 2–5% of all patients with uterine malignancies; however, the morbidity of uterine sarcoma is low compared with that of other gynecological cancers.
Saya Tamura +5 more
doaj +1 more source